Live feed
Filing
SCHEDULE 13D/A
SCHEDULE 13D/A0001415889-25-002988·Immunome Aggregator, LP
Schedule 13D ownership disclosure
Immunome Inc
Common Stock, par value $0.0001 per share · CUSIP: 45257U108
Event date: 2025-01-31
Reporting persons may disclose overlapping interests. Their amounts are shown individually and are not added into a filing total.
- Filing-level shares
- Unavailable
- Percent of class
- Unavailable
- Immunome Aggregator, LPReported CIK 0001996276
Shares: 4,768,583.00 · Class: 6.0%
- Enavate Sciences GP, LLCReported CIK 0001953107
Shares: 4,768,583.00 · Class: 6.0%
Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.
Source: SEC EDGAR filingFiling metadata
- Accession number
- 0001415889-25-002988
- Form type
- SCHEDULE 13D/A
- Filer
- Immunome Aggregator, LP
- CIK
- CIK 1996276
- Filed
- Feb 04, 2025
- Reporting period
- Jan 31, 2025
- Description
- Schedule 13D beneficial ownership